Compare RETO & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RETO | ACON |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5M | 6.6M |
| IPO Year | 2016 | 2022 |
| Metric | RETO | ACON |
|---|---|---|
| Price | $1.40 | $2.31 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 42.2M | 36.9K |
| Earning Date | 10-20-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.82 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $75,730.00 |
| Revenue This Year | N/A | $44.55 |
| Revenue Next Year | N/A | $123.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 65.62 |
| 52 Week Low | $0.09 | $1.95 |
| 52 Week High | $7.84 | $12.03 |
| Indicator | RETO | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 44.00 |
| Support Level | $0.54 | $2.33 |
| Resistance Level | $1.57 | $2.50 |
| Average True Range (ATR) | 0.12 | 0.16 |
| MACD | 0.16 | -0.03 |
| Stochastic Oscillator | 55.94 | 7.30 |
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation, and construction of urban ecological environments for capturing, controlling, and reusing rainwater. It operates through two segments, namely Equipment and technical service segment, and Craft beer segment. The company earns its revenue from the Equipment and technical service segment. Geographically, it derives a majority of its revenue from China.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.